Concepedia

Author

Greg Holtz

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Greg Holtz

5

Publications

457

Citations

5

H-Index

17

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Case Western Reserve University
GH

About

Greg Holtz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, molecular genetics, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

350

2

Biochemistry

2

2

229

3

Molecular Genetics

2

2

121

4

Biology

1

1

19

5

Cell Biology

1

1

102

Greg Holtz

×

5

Publications

457

Citations

5

H-Index

YearCitations

In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)

Jeffery J. Anderson, Margaret Bradbury, Darlene R. Giracello,

European Journal of Pharmacology

2003

136

[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization

Jeffery J. Anderson, Sara Rao, Blake A. Rowe,

Journal of Pharmacology and Experimental Therapeutics

2002

107

Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice

Bruce Lamb, Kimberly A. Bardel, Laura Shapiro Kulnane,

Nature Neuroscience

1999

102

Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897

Jeffery J. Anderson, Greg Holtz, Patricia Baskin,

Biochemical Pharmacology

2005

93

Control of basal-level codon misreading in Escherichiacoli

Jack Parker, Greg Holtz

Biochemical and Biophysical Research Communications

1984

19

Page 1